Cytek Biosciences Balance Sheet
Cytek Biosciences's total assets for Q4 2025 were $461.54M, a decrease of -6.74% from the previous quarter. CTKB total liabilities were $119.80M for the fiscal quarter, a 2.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.